Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-23 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
285,000 | $0 | 285,000 (Direct) |
View |
| 2024-12-02 Option Award |
2024-12-06 4:32 pm |
N/A 2034-12-01 |
Aileron Therapeutics Inc. | ALRN | Musso Alan A Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-08-20 Option Award |
2024-08-22 4:05 pm |
N/A 2034-08-19 |
Aileron Therapeutics Inc. | ALRN | Musso Alan A Director |
2,725 | $0 | 2,725 (Direct) |
View |
| 2024-01-26 Option Award |
2024-01-30 9:05 pm |
N/A 2034-01-25 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 4:15 pm |
2024-02-07 2033-08-06 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
61,822 | $0 | 61,822 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 8:53 pm |
N/A 2033-10-30 |
AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director |
5,450 | $0 | 5,450 (Direct) |
View |
Ownership |
2023-11-02 8:51 pm |
N/A 2032-05-08 |
AILERON THERAPEUTICS INC | ALRN | Musso Alan A Director |
0 | $0 | 17,064 (Direct) |
View |
| 2023-08-07 Option Award |
2023-08-09 4:16 pm |
N/A 2033-08-06 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
432,800 | $0 | 432,800 (Direct) |
View |
Ownership |
2023-08-09 4:11 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |